Soy isoflavones
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
139 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | — | 13 | 5 | 1 | 2 | 20 |
| Osteoporosis | D010024 | EFO_0003882 | M81.0 | 2 | 2 | 3 | 1 | 5 | 13 |
| Menopause | D008593 | EFO_0003922 | N95 | — | 1 | 2 | 1 | 8 | 12 |
| Hot flashes | D019584 | — | — | — | 3 | 2 | 4 | — | 9 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | 2 | 1 | 1 | 3 | 8 |
| Asthma | D001249 | EFO_0000270 | J45 | — | 1 | — | 1 | 2 | 4 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | 1 | — | 1 |
| Overweight | D050177 | — | E66.3 | — | — | — | 1 | — | 1 |
| Drug interactions | D004347 | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 5 | 1 | — | 6 | 13 |
| Metabolic bone diseases | D001851 | — | — | 1 | 1 | 3 | — | 2 | 7 |
| Postmenopause | D017698 | — | — | — | 1 | 1 | — | 2 | 4 |
| Neoplasms | D009369 | — | C80 | — | 1 | 1 | — | 1 | 3 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | 1 | — | 2 | 3 |
| Bone density | D015519 | EFO_0003923 | M85 | — | — | 1 | — | — | 1 |
| Osteosclerosis | D010026 | — | Q78.2 | — | — | 1 | — | — | 1 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 1 | 1 | — | — | 1 |
| Severe acute malnutrition | D000067011 | — | — | — | 1 | 1 | — | — | 1 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | 1 | — | — | 1 |
Show 7 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast carcinoma in situ | D000071960 | — | D05 | — | 1 | — | — | 1 | 2 |
| Intraductal carcinoma noninfiltrating | D002285 | — | D05.1 | — | 1 | — | — | 1 | 2 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | — | — | 1 | 2 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | 1 | — | — | 1 | 2 |
| Depression | D003863 | — | F33.9 | — | 2 | — | — | — | 2 |
| Renal insufficiency | D051437 | — | N19 | — | 1 | — | — | 1 | 2 |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | 1 | 1 | — | — | — | 1 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 1 | — | — | — | 1 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | — | — | — | 1 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | — | 1 | — | — | — | 1 |
Show 28 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | 1 | 2 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
| Squamous cell neoplasms | D018307 | — | — | 1 | — | — | — | — | 1 |
| Adenosquamous carcinoma | D018196 | — | — | 1 | — | — | — | — | 1 |
| Adenocarcinoma of lung | D000077192 | — | — | 1 | — | — | — | — | 1 |
| Bronchiolo-alveolar adenocarcinoma | D002282 | — | — | 1 | — | — | — | — | 1 |
| Gestational diabetes | D016640 | — | O24.4 | 1 | — | — | — | — | 1 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | — | 1 |
| Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | — | 1 |
Show 1 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 4 | 4 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 4 | 4 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 3 | 3 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 3 | 3 |
| Peritoneal dialysis | D010530 | — | — | — | — | — | — | 2 | 2 |
| Abdominal obesity | D056128 | — | — | — | — | — | — | 2 | 2 |
| Heart disease risk factors | D000082742 | — | — | — | — | — | — | 2 | 2 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | — | 2 | 2 |
| Hypercholesterolemia | D006937 | — | — | — | — | — | — | 2 | 2 |
| Immunologic deficiency syndromes | D007153 | — | D84.9 | — | — | — | — | 2 | 2 |
Show 46 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
21 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use